1,7-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 98%, 250mg

Methyl 2-(4,6-dichloropyrimidin-5-yl)acetate, 95.0%, 1g

4-(Morpholine-4-sulfonyl)-benzoic acid, 95.0%, 5g

4-Thiouridine>95.0%(qNMR)100mg

methyl 4-amino-1H-1,2,3-benzotriazole-6-carboxylate, 95%, 100mg

1-(3-Chloropropoxy)-4-fluorobenzene, 99.0%, 100g

Methyl 1-amino-4-bromo-1H-pyrrole-2-carboxylate monohydrochloride, 250mg

(25-35% Methylethylhydrosiloxane)-dimethylsiloxane copolymer, trimethylsiloxane terminated, reduced volatility, 100g

1-Chloro-3,5-di(propan-2-yl)benzene, 97%, 5g

2-Hydroxy-5-methyl-3-nitropyridine>98.0%(GC)(T)25g

Oxcarbazepine>98.0%(HPLC)(N)5g

Indican, 99.41%, 1g

2-(2-Aminoethyl)pyridazin-3(2{H})-one, 95.0%, 250mg